Associated Papers
Comprehensive structure-function analysis reveals gain- and loss-of-function mechanisms impacting oncogenic KRAS activity.
Kwon JJ et al.
Biorxiv : the Preprint Server for Biology, 2024
39484452 (PubMed )
Supplement: media-2.zip › Extended_Data_Tables › Extended_Data_Table_1.xlsx › KRAS_GOF_DMS_Screen
Hydrophobic interactions dominate the recognition of a KRAS G12V neoantigen.
Wright KM et al.
Nature Communications, 2023
37604828 (PubMed )
Supplement: 41467_2023_40821_MOESM4_ESM.xlsx › Sheet1
Oncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site.
Mazhab-Jafari MT et al.
Proceedings of the National Academy of Sciences of the United States of America, 2015
Select a paper to view details